MedTech Association adds six new industry leaders to Board of Directors
Thursday, November 16, 2017
MedTech Association, a membership-based trade association for the bioscience and medical technology (Bio/Med) industry in New York State, has added six highly-qualified community and industry leaders to its 2017-2018 board of directors. MedTech appreciates the distinguished efforts of its 2017-2018 board and looks forward to advancing the organization's mission with its new directors. For a complete listing of MedTech directors, visit http://www.medtech.org/about/board-of-directors/.
Associate Director Client Services & Director of Business Development, Axon Communications
Jennifer M. Barrett, MSc is an experienced health communication professional dedicated to improving health outcomes. She has focused her career on building awareness through health education, marketing and rebranding initiatives that result in behavior modification. She develops creative strategic communication and marketing plans that address disease prevention, health promotion, patient advocacy and support, improvements in quality of care, as well as educating on the social model of patient care. She has been an integral leader in health collaboration initiatives providing unique solutions to address evolving health care industry trends. Jennifer received her undergraduate degree from Fairfield University and holds a Master of Science in Health Communication from Boston University. She is active in her industry as a member of CURE and Healthcare Business Women’s Association.
President & CEO, iuvo BioScience
Prior to co-founding iuvo BioScience and taking on the roles of President and CEO, Ben was Vice President of Quality for the Pharmaceutical, Solutions and External Manufacturing organizations of Valeant Pharmaceuticals. Prior to the acquisition of Bausch + Lomb by Valeant, Ben served as Global VP of Quality for the Pharmaceutical Business Unit, and was a member of the B+L Global Leadership Team. Earlier in his career, he held the position of Director, Quality and Technical Services for Norwich Pharmaceuticals. He began his career with Procter & Gamble Pharmaceuticals as a Process Engineer, moving up to roles of increasing responsibility in Product Development, OTC Engineering (Cayey, PR) and Global Clinical Supplies. He holds a BS from Carnegie Mellon University with a double major in Chemical Engineering and Biomedical Engineering, and a dual MS/MAT in Chemistry and Education from Binghamton University.
Director of Operations and Innovation Partnerships, CNY Biotech Accelerator
Kathi Durdon, MA, CCRP, is Director of Operations and Innovation Partnerships at the CNY Biotech Accelerator (CNYBAC), a division of Upstate Medical University in Syracuse, NY. As Director of CNYBAC, Kathi promotes effective and transparent operational procedures for the 60,000 square foot specialized multi-use biotech facility, CNYBAC. She develops biotech innovation-oriented programs, coordinates resources and promotes educational and investment opportunities for clients and the startup community and mentors medical device innovators relative to Good Clinical Practice regulations, FDA submission requirements and device classification as well as human factors usability testing. Kathi holds Bachelor’s degrees in English and Anthropology and a Master’s degree in Business. Previously, Kathi was employed at Welch Allyn, a medical device manufacturer, as Manager of Clinical Affairs and as Director, Clinical Trials at SUNY Upstate Medical University.
Irfan Khan, MD
Founder & Chief Strategy Officer, Circuit Clinical
Irfan Khan is the Founder and Chief Strategy Officer of Circuit Clinical - a rapidly scaling clinical research site network powered by proprietary data management software. In this role he is responsible for Circuit's strategic positioning and all business development and industry engagement. He has also been a clinical research investigator for almost 15 years and as a partner in Buffalo Heart Group built its electrophysiology clinical research program. Dr. Khan is a Board Certified clinical cardiac electrophysiologist trained at Case Western Reserve University and has performed thousands of cardiac procedures in his past role as the Director of the Electrophysiology program at Mercy Hospital of Buffalo. Dr. Khan is a passionate advocate for patient education and responsibility and speaks frequently on these topics, including a 2014 TEDx appearance on prevention of sudden death.
Vice President, Tanner-Ibbotson, Inc.
Brian Toglia is currently a partner and life science practice leader at Tanner-Ibbotson, Inc. In this role, he advises clients on their various exposures to loss during each phase of business development and leverages his relationship in the marketplace to deliver comprehensive insurance solutions. Toglia has 12 years of risk management experience and has been specifically focusing on the life science industry since 2013. His practice has expanded beyond the borders of New York State where is currently licensed in 12 States and growing. Beyond his role at Tanner-Ibbotson, Toglia is actively involved in the life science community, particularly in NY. In 2016, he was named MedTech Association Member of the Year in recognition of his contributions to the industry. He also serves on the advisory council for the Binghamton University School of Pharmacy & Pharmaceutical Studies. Toglia also contributes at an educational level on topics such as Insurance 101 for Biotech Startups, CFC 21 Part 11 (Cyber Security) and International Clinical Trials. Toglia holds 2 bachelor degrees from Pepperdine University in Business and Political Science.
Director, The Kevin M. McGovern Family Center for Venture Development in the Life Sciences, Cornell University
Lou Walcer was appointed in June 2011 as the first Director of the Kevin M. McGovern Family Center for Venture Development in the Life Sciences at Cornell University. Lou’s career spans 40 years in drug, medical device, vaccine, and diagnostic product development as Entrepreneur, Consultant, Manager, Director, Company Officer and President. From 2006-2011, Lou had served as Consultant to, then Senior Commercialization Executive for New Ventures at Cleveland Clinic Innovations where he managed a portfolio of 30 startups, and planned, created and obtained initial investment funding for 10, which eventually netted two licenses, one IPO, and 3 exits by sale for that institution. Lou earned a B.A. degree from Cornell University, and his M.B.A. from New York University. He has served as Director, Vice Chair, and Chairman of the Board of Directors of the Business Incubator Association of New York State